Oramed Pharmaceuticals Inc. Gains 44.37%
Fri, Jul 08, 2022 at 08:31 PM
Oramed Pharmaceuticals Inc. (ORMP:NASDAQ) shot up at $8.2, representing a gain of 44.4%. On Fri, Jul 08, 2022, ORMP:NASDAQ hit a New 2-Week High of $8.2. The stock appeared on our News Catalysts scanner on Thu, Jul 07, 2022 at 10:39 AM in the 'LETTER TO STOCKHOLDERS' category. From Fri, Jun 24, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days
About Oramed Pharmaceuticals Inc. (ORMP:NASDAQ)
Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
Top 10 Gainers:
- Seritage Growth Properties (SRG:NYSE), 80.26%
- Aditxt Inc. (ADTX:NASDAQ), 50%
- Waitr Holdings Inc. (WTRH:NASDAQ), 48.49%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 44.37%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- MyMD Pharmaceuticals Inc. (MYMD:NASDAQ), 42.14%
- Kura Sushi USA, Inc. (KRUS:NASDAQ), 33.62%
- PhaseBio Pharmaceuticals, Inc. (PHAS:NASDAQ), 32.22%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 29.17%
- Immuneering Corporation (IMRX:NASDAQ), 28.85%